BNP Paribas Financial Markets’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VCM
EAM
VFT
DAM
BNP Paribas Financial Markets's PASG Position: Q2 2026 in Review
BNP Paribas Financial Markets held its Passage Bio (PASG) position steady in Q2 2026 at 12 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #5822.
BNP Paribas Financial Markets first reported a position in PASG in Q4 2024 and has held it in 7 quarters since. The position peaked at $142 in Q4 2025. 19 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- BNP Paribas Financial Markets held 12 shares of Passage Bio worth $59 as of Q2 2026.
- BNP Paribas Financial Markets left its Passage Bio share count unchanged in Q2 2026.
- Passage Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5822 holding.
- BNP Paribas Financial Markets first reported a position in Passage Bio in Q4 2024 and has held it in 7 quarters since.
- BNP Paribas Financial Markets's Passage Bio position peaked at $142 in Q4 2025.
- 19 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.